Ebrahim Versi - 15 Sep 2023 Form 4 Insider Report for DMK PHARMACEUTICALS Corp

Signature
/s/ David J. Marguglio, as Attorney-in-Fact for Ebrahim Versi
Issuer symbol
N/A
Transactions as of
15 Sep 2023
Net transactions value
$0
Form type
4
Filing time
19 Sep 2023, 17:17:24 UTC
Previous filing
30 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMP Common Stock Conversion of derivative security $0 +729,200 +412% $0.000000 906,394 15 Sep 2023 By Versi Group LLC F1, F2
holding ADMP Common Stock 8,745 15 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMP Series E Convertible Preferred Stock Conversion of derivative security $0 -729 -38% $0.000000 1,212 15 Sep 2023 Common Stock 729,200 By Versi Group LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 15, 2023, Versi Group, LLC converted 729.2 shares of Series E Convertible Preferred Stock ("Series E Preferred") into 729,200 shares of Common Stock, pursuant to the terms of the Series E Preferred. Each share of Series E Preferred is convertible into 1,000 shares of Common Stock at the election of the reporting person, subject to certain beneficial ownership limitations. The Series E Preferred has no expiration date.
F2 The reported shares are owned directly by Versi Group, LLC, of which the reporting person is the manager and a member. The reporting person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interests therein.